Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Transdermal nicotine reduces cigarette craving and nicotine preference.

Publication ,  Journal Article
Rose, JE; Herskovic, JE; Trilling, Y; Jarvik, ME
Published in: Clin Pharmacol Ther
October 1985

The effects of transdermal nicotine in 10 cigarette smokers were studied in a within-subjects, double-blind design. Either 8 mg nicotine base in a 30% aqueous solution or an inactive placebo solution was applied to intact skin under a polyethylene patch. Subjective reports of cigarette craving were collected every 30 minutes during a 90-minute smoking abstinence period. Immediately before and after this abstinence period subjects smoked through a smoke mixing device that allowed them to select their desired nicotine intake with each puff. Transdermal nicotine significantly increased saliva nicotine levels within 30 minutes after application. Cigarette craving was significantly lower in the nicotine condition than in the placebo condition. Nicotine preference during the initial puffs of the smoke mixer test at the end of 90 minutes of deprivation was also decreased by transdermal nicotine. In contrast, measures of cumulative smoke intake were not affected by the nicotine dose used. Our results suggest that transdermal nicotine may enhance success in smoking cessation by preventing the rise in cigarette craving usually observed after cessation. Transdermal nicotine may be preferable to other routes of nicotine administration because of the relative absence of adverse side effects.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Pharmacol Ther

DOI

ISSN

0009-9236

Publication Date

October 1985

Volume

38

Issue

4

Start / End Page

450 / 456

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Smoking Prevention
  • Skin Absorption
  • Saliva
  • Pharmacology & Pharmacy
  • Nicotine
  • Male
  • Hydrogen-Ion Concentration
  • Humans
  • Heart Rate
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rose, J. E., Herskovic, J. E., Trilling, Y., & Jarvik, M. E. (1985). Transdermal nicotine reduces cigarette craving and nicotine preference. Clin Pharmacol Ther, 38(4), 450–456. https://doi.org/10.1038/clpt.1985.203
Rose, J. E., J. E. Herskovic, Y. Trilling, and M. E. Jarvik. “Transdermal nicotine reduces cigarette craving and nicotine preference.Clin Pharmacol Ther 38, no. 4 (October 1985): 450–56. https://doi.org/10.1038/clpt.1985.203.
Rose JE, Herskovic JE, Trilling Y, Jarvik ME. Transdermal nicotine reduces cigarette craving and nicotine preference. Clin Pharmacol Ther. 1985 Oct;38(4):450–6.
Rose, J. E., et al. “Transdermal nicotine reduces cigarette craving and nicotine preference.Clin Pharmacol Ther, vol. 38, no. 4, Oct. 1985, pp. 450–56. Pubmed, doi:10.1038/clpt.1985.203.
Rose JE, Herskovic JE, Trilling Y, Jarvik ME. Transdermal nicotine reduces cigarette craving and nicotine preference. Clin Pharmacol Ther. 1985 Oct;38(4):450–456.
Journal cover image

Published In

Clin Pharmacol Ther

DOI

ISSN

0009-9236

Publication Date

October 1985

Volume

38

Issue

4

Start / End Page

450 / 456

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Smoking Prevention
  • Skin Absorption
  • Saliva
  • Pharmacology & Pharmacy
  • Nicotine
  • Male
  • Hydrogen-Ion Concentration
  • Humans
  • Heart Rate